<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04153461</url>
  </required_header>
  <id_info>
    <org_study_id>MiniPNL</org_study_id>
    <nct_id>NCT04153461</nct_id>
  </id_info>
  <brief_title>Mini- Percutaneous Nephrolithotomy Versus Standard Percutaneous Nephrolithotomy in the Treatment of Renal Stones.</brief_title>
  <official_title>Mini- Percutaneous Nephrolithotomy Versus Standard Percutaneous Nephrolithotomy in the Treatment of Renal Stones. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The EUA Urolithiasis Guidelines Panel meta-analysis suggest that mPNL is at least as
      efficacious and safe as sPNL for the removal of renal calculi. However, the quality of the
      evidence was poor, drawn mainly from small studies, the majority of which were single-arm
      case series, and only one of which was RCT. The risks of bias and confounding were high,
      highlighting the need for more reliable data from RCTs. So, the Panel recommended for more
      clinical research .

      The aim of this study is to compare between PNL and mPNL through a randomized controlled
      trial.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of stone free rate (SFR)</measure>
    <time_frame>2 years</time_frame>
    <description>defined as less than 4mm by non contrast computed tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>assessment of haemoglobin loss</measure>
    <time_frame>2 years</time_frame>
    <description>measured by haemoglobin change pre and postoperative (measured by grams/ deciliter)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of pain</measure>
    <time_frame>2 years</time_frame>
    <description>measured by visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of renal function</measure>
    <time_frame>2 years</time_frame>
    <description>measured by serum creatinine measured by Milligram/ deciliter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of patient satisfaction</measure>
    <time_frame>2 years</time_frame>
    <description>measured by freiburg index of patient satisfaction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Urolithiasis</condition>
  <condition>Stone;Renal</condition>
  <condition>Nephrolithiasis</condition>
  <condition>PNL</condition>
  <condition>PCNL</condition>
  <condition>NEPHROLITHOTOMY</condition>
  <condition>MINIPERC</condition>
  <arm_group>
    <arm_group_label>MINI-PERCUTANEOUS NEPHROLITHOTOMY</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>MINIPERCUTANEOUS NEPHROLITHOTOMY USING NEPHROSCOPY 15 FR, LASER DUSTING OF THE STONE, NEPHROSTOMY TUBE 12 FIXATION</description>
  </arm_group>
  <arm_group>
    <arm_group_label>STANDARD PERCUTANEOUS NEPHROLITHOTOMY</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PERCUTANEOUS NEPHROLITHOTOMY USING NEPHROSCOPY 24 FR, ULTRASOUND OR LITHOCLAST DISINTEGRATION OF THE STONE AND FORCEPS EXTRACTION OF THE FRAGMENTS, NEPHROSTOMY TUBE 22 FIXATION</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MINI-PERCUTANEOUS NEPHROLITHOTOMY</intervention_name>
    <description>MINIPERCUTANEOUS NEPHROLITHOTOMY USING NEPHROSCOPY 15 FR, LASER DUSTING OF THE STONE, NEPHROSTOMY TUBE 12 FIXATION</description>
    <arm_group_label>MINI-PERCUTANEOUS NEPHROLITHOTOMY</arm_group_label>
    <other_name>MINIPERC</other_name>
    <other_name>MINI-PERC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>STANDARD PERCUTANEOUS NEPHROLITHOTOMY</intervention_name>
    <description>PERCUTANEOUS NEPHROLITHOTOMY USING NEPHROSCOPY 24 FR, ULTRASOUND OR LITHOCLAST DISINTEGRATION OF THE STONE AND FORCEPS EXTRACTION OF THE FRAGMENTS, NEPHROSTOMY TUBE 22 FIXATION</description>
    <arm_group_label>STANDARD PERCUTANEOUS NEPHROLITHOTOMY</arm_group_label>
    <other_name>PNL</other_name>
    <other_name>PCNL</other_name>
    <other_name>STANDARD PNL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient 18 years or older.

          2. ASA I or II

          3. Renal stones ≥ 2 cm

          4. Lower calyceal stone ≥ 1 cm

          5. Failure of other modalities of treatment as ESWL and RIRS.

        Exclusion Criteria:

          1. S.creatinine &gt; 2mg/dl.

          2. Patients with active UTI.

          3. Patients on anticoagulant.

          4. Age &lt;18 years.

          5. Ureteral obstruction preventing the insertion of a ureteral stent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Urology and Nephrology Center</name>
      <address>
        <city>Mansoura</city>
        <state>Aldakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 4, 2019</study_first_submitted>
  <study_first_submitted_qc>November 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2019</study_first_posted>
  <last_update_submitted>November 10, 2019</last_update_submitted>
  <last_update_submitted_qc>November 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mostafa Elgamal</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>urolithiasis</keyword>
  <keyword>stone, renal</keyword>
  <keyword>nephrolithiasis</keyword>
  <keyword>PNL</keyword>
  <keyword>PCNL</keyword>
  <keyword>NEPHROLITHOTOMY</keyword>
  <keyword>MINIPERC</keyword>
  <keyword>MINI-PERC</keyword>
  <keyword>BLOOD LOSS</keyword>
  <keyword>NEPHROSTOMY SIZE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urolithiasis</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

